Paper46009
Letter: Levamisole in rheumatoid arthritis.
Schuermans Y. Lancet, 1975. Cited by 87 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Letter: Levamisole in rheumatoid arthritis. Papers, record 46009. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/46009
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Arthritis, Rheumatoid | Major topic |
| Levamisole | Major topic |
| Adult | |
| Aged | |
| Female | |
| Humans | |
| Male | |
| Middle Aged | |
| Time Factors |
Source PubMed
Cited by10
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 87 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 23,024,819 | Synthesis and antiangiogenic activity of N-alkylated levamisole derivatives. | PLoS One | 2012 | https://conductscience.org/library/papers/23024819 | PubMed |
| 7,166,176 | Pharmacokinetics of levamisole in healthy subjects and cancer patients. | Eur J Drug Metab Pharmacokinet | 1982 | https://conductscience.org/library/papers/7166176 | PubMed |
| 7,009,134 | Antirheumatic drugs: clinical pharmacology and therapeutic use. | Drugs | 1980 | https://conductscience.org/library/papers/7009134 | PubMed |
| 6,768,438 | Remission-inducing drugs in rheumatoid arthritis. | Can Med Assoc J | 1980 | https://conductscience.org/library/papers/6768438 | PubMed |
| 930,758 | The effect of drugs in established rabbit monoarticular arthritis. | Agents Actions | 1977 | https://conductscience.org/library/papers/930758 | PubMed |
| 680,948 | Restoration of methotrexate-suppressed oxazolone-induced contact sensitivity with levamisole. | Inflammation | 1978 | https://conductscience.org/library/papers/680948 | PubMed |
| 629,595 | Neutrophil chemotaxis in rheumatoid arthritis. Effect of D-penicillamine, gold salts, and levamisole. | Ann Rheum Dis | 1978 | https://conductscience.org/library/papers/629595 | PubMed |
| 624,030 | Cutaneous necrotising vasculitis induced by levamisole. | Br Med J | 1978 | https://conductscience.org/library/papers/624030 | PubMed |
| 617,957 | Condition-dependent immunoregulatory control of contact sensitivity by levamisole. | Inflammation | 1977 | https://conductscience.org/library/papers/617957 | PubMed |
| 104,929 | Immunopharmacology of gold sodium thiomalate and auranofin (SK&F D-39162): effects on cell-mediated immunity. | Inflammation | 1978 | https://conductscience.org/library/papers/104929 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/46009
GET https://conductscience.org/api/papers/v1/46009/authors